Ashraf S, et al.Trials. 2021 Sep 6;22(1):591. doi: 10.1186/s13063-021-05487-z.Trials. 2021.PMID: 34488858
. Mini Rev Med Chem. 2021 Feb 19. doi: 10.2174/1389557521666210219161747. Online ahead of print.Mini Rev Med Chem. 2021.PMID: 33605857
.
Item in Clipboard
The EDS1-PAD4-ADR1 node mediates Arabidopsis pattern-triggered immunity.
Pruitt RN, Locci F, Wanke F, Zhang L, Saile SC, Joe A, Karelina D, Hua C, Fröhlich K, Wan WL, Hu M, Rao S, Stolze SC, Harzen A, Gust AA, Harter K, Joosten MHAJ, Thomma BPHJ, Zhou JM, Dangl JL, Weigel D, Nakagami H, Oecking C, Kasmi FE, Parker JE, Nürnberger T.
.
.
Item in Clipboard
. Schoenfeld AJ, et al.Ann Oncol. 2021 Sep 3:S0923-7534(21)04455-0. doi: 10.1016/j.annonc.2021.08.2151. Online ahead of print.Ann Oncol. 2021.PMID: 34487855
.
.
Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
Ashraf S, Ashraf S, Farooq I, Ashraf S, Ashraf M, Imran MA, Kalsoom L, Akmal R, Ghufran M, Rafique S, Akram MK, Habib Z, Siddiqui UN, Ahmad A, Arshad S, Virk MAR, Gul M, Awais AB, Hassan M, Sherazi SSH, Safdar Z, Munir I, Khalid H, Munir K, Majeed N, Alahmadi YM, Humayun A, Saboor QA, Ahmad A, Ashraf M, Izhar M; DOCTORS LOUNGE Consortium.